Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,289 | 55 | 95.3% |
| Education | $63.95 | 2 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $430.66 | 19 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $239.00 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $108.27 | 3 | $0 (2021) |
| Celgene Corporation | $89.43 | 4 | $0 (2022) |
| Ardelyx, Inc. | $75.18 | 3 | $0 (2023) |
| Amgen Inc. | $65.69 | 3 | $0 (2021) |
| VYNE Pharmaceuticals Inc. | $60.33 | 3 | $0 (2021) |
| Braintree Laboratories, Inc. | $52.38 | 2 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $45.26 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $63.52 | 3 | Ardelyx, Inc. ($22.41) |
| 2022 | $408.88 | 13 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2021 | $880.10 | 41 | AbbVie Inc. ($390.13) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Gastroenterology | ||||||
| 04/19/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/27/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Gastroenterology | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Gastroenterology | ||||||
| 09/28/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Neuroscience | ||||||
| 09/23/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: Neuroscience | ||||||
| 08/02/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: VIROLOGY | ||||||
| 07/29/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: GI COLON PREP | ||||||
| 07/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Gastroenterology | ||||||
| 06/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Gastroenterology | ||||||
| 06/03/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Neuroscience | ||||||
| 05/12/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
| 05/12/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: Neuroscience | ||||||
| 10/27/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Immunology | ||||||
| 10/05/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $56.99 | General |
| Category: Immunology | ||||||
| 09/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Gastroenterology | ||||||
| 06/29/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: VIROLOGY | ||||||
| 06/22/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $117.52 | General |
| 06/22/2021 | AbbVie Inc. | — | Education | In-kind items and services | $6.96 | General |
| 06/15/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Immunology | ||||||
| 06/09/2021 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 06/07/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 14 | 14 | $490.00 | $58.30 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2022 | 14 | 14 | $490.00 | $58.30 | 11.9% |
About Ran Choi
Ran Choi is a Medical healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1053652115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ran Choi has received a total of $1,353 in payments from pharmaceutical and medical device companies, with $63.52 received in 2023. These payments were reported across 57 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,289).
As a Medicare-enrolled provider, Choi has provided services to 14 Medicare beneficiaries, totaling 14 services with total Medicare billing of $58.30. Data is available for 1 year (2022–2022), covering 1 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location New Hyde Park, NY
- Active Since 03/13/2013
- Last Updated 06/06/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053652115
Products in Payments
- XIFAXAN (Drug) $239.00
- ZEPOSIA (Drug) $214.43
- HUMIRA (Biological) $129.31
- STELARA (Biological) $108.27
- MAVYRET (Drug) $101.46
- IBSRELA (Drug) $75.18
- Otezla (Drug) $65.69
- AMZEEQ (Drug) $60.33
- CREON (Drug) $53.33
- SUTAB (Drug) $52.38
- OCALIVA (Drug) $45.26
- Linzess (Drug) $24.43
- VIBERZI (Drug) $22.08
- AMELUZ (Drug) $17.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in New Hyde Park
Susan Lehrman, Rpa-C, RPA-C
Medical — Payments: $4,489
Nikita Farhadi
Medical — Payments: $3,379
Stanley Johnson, Pa-C, PA-C
Medical — Payments: $3,245
Libby Ludwig, Rpa-C, Mpa, RPA-C, MPA
Medical — Payments: $2,524
Mr. Yaron Shalomoff, Rpa-C, RPA-C
Medical — Payments: $2,164
Stephen Palazzolo
Medical — Payments: $1,491